Marie Thibault
Stock Analyst at BTIG
(4.01)
# 568
Out of 5,090 analysts
100
Total ratings
56.52%
Success rate
10.11%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Buy | $198 → $200 | $141.96 | +40.88% | 7 | Dec 4, 2025 | |
| EW Edwards Lifesciences | Reiterates: Buy | $100 | $85.78 | +16.58% | 1 | Nov 25, 2025 | |
| HAE Haemonetics | Reiterates: Buy | $88 | $83.81 | +5.00% | 3 | Nov 21, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $97.72 | +35.08% | 14 | Nov 21, 2025 | |
| PODD Insulet | Maintains: Buy | $370 → $380 | $316.45 | +20.08% | 6 | Nov 21, 2025 | |
| ABT Abbott Laboratories | Reiterates: Buy | $145 | $125.40 | +15.63% | 14 | Nov 20, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $32 | $24.35 | +31.42% | 1 | Nov 18, 2025 | |
| OM Outset Medical | Maintains: Buy | $39 → $17 | $4.71 | +260.93% | 1 | Nov 11, 2025 | |
| ARAY Accuray | Maintains: Buy | $5 → $4 | $1.03 | +290.24% | 2 | Nov 6, 2025 | |
| DCTH Delcath Systems | Reiterates: Buy | $23 | $10.09 | +127.95% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $85 | $65.27 | +30.23% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $215 | $181.60 | +18.39% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.18 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $11.70 | +113.77% | 3 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.71 | - | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $52 | $39.36 | +32.11% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $71.01 | -8.46% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.29 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.90 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.47 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.74 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $350.00 | -98.29% | 1 | Apr 9, 2020 |
Masimo
Dec 4, 2025
Maintains: Buy
Price Target: $198 → $200
Current: $141.96
Upside: +40.88%
Edwards Lifesciences
Nov 25, 2025
Reiterates: Buy
Price Target: $100
Current: $85.78
Upside: +16.58%
Haemonetics
Nov 21, 2025
Reiterates: Buy
Price Target: $88
Current: $83.81
Upside: +5.00%
Boston Scientific
Nov 21, 2025
Reiterates: Buy
Price Target: $132
Current: $97.72
Upside: +35.08%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $370 → $380
Current: $316.45
Upside: +20.08%
Abbott Laboratories
Nov 20, 2025
Reiterates: Buy
Price Target: $145
Current: $125.40
Upside: +15.63%
Kestra Medical Technologies
Nov 18, 2025
Initiates: Buy
Price Target: $32
Current: $24.35
Upside: +31.42%
Outset Medical
Nov 11, 2025
Maintains: Buy
Price Target: $39 → $17
Current: $4.71
Upside: +260.93%
Accuray
Nov 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.03
Upside: +290.24%
Delcath Systems
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $10.09
Upside: +127.95%
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $65.27
Upside: +30.23%
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $181.60
Upside: +18.39%
Oct 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.18
Upside: -
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $11.70
Upside: +113.77%
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.71
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $39.36
Upside: +32.11%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $71.01
Upside: -8.46%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.90
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.47
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.74
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $350.00
Upside: -98.29%